// App-Quantinova.ai

963 : Epigenetic silencing of miR-199a-3p is associated with increased cell survival, enhanced cell motility, and sensitivity to tivantinib through regulation of c-Met expression in hepatocellular carcinoma

Researchers

Presenter

  • Kohichiroh Yasui

Principal Investigators

  • Akira Tomie

  • Naoto Iwai

  • Tomoko Kitaichi

  • Osamu Dohi

  • Yasuyuki Gen

  • Yoshito Itoh

Medical Centers

  • Kyoto Prefectural University of Medicine, Suita, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Focal Adhesion Kinase

  • Hepatocyte growth factor receptor

  • DNA methylation

Drug/Treatment

  • Tivantinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved